Healthcare Technology · medium ·

Scheduling-integrated infusion costing helps academic medical centres defend treatment margins against competition from independent outpatient suites

Hospital health systems are experiencing rapid margin contraction as profitable specialty pharmaceutical infusions shift permanently out of hospital wards and into independent ambulatory infusion suites. In response, academic medical centres are abandoning aggregate accounting in favour of procedure-level micro-costing modules directly integrated into clinical scheduling systems. Tracking variable drug acquisition costs and real-time chair utilisation down to individual patient minutes has become essential to defend clinical contribution margins.

Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.

Related opportunities